Industries > Pharma > Companion Animal Diagnostics Market Report 2021-2031
Companion Animal Diagnostics Market Report 2021-2031
Forecasts by Technology (Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics, and Others), by Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Pregnancy testing, Genetic testing, and Toxicology testing), by Animal Type (Dogs, Cats, Horses, Rabbits, Birds, and Others), by End User (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities) by Distribution Channel (Direct Tender, and Retail Sales) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios
Companion Animal Diagnostics Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Companion Animal Diagnostics is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 250+ page report provides 420+ tables and 380+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Companion Animal Diagnostics Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Companion Animal Diagnostics Market By Technology
• Clinical Chemistry Analysis
o Clinical Chemistry Reagent Clips and Cartridges
o Clinical Chemistry Analyzers
• Glucose Monitoring
o Blood Glucose Strips
o Glucose Monitors
o Urine Glucose Strips
• Blood Gas & Electrolyte Analysis
o Blood Gas & Electrolyte Reagent Clips and Cartridges
o Blood Gas & Electrolyte Analyzers
• Immunodiagnostics
o Lateral Flow Assays
o ELISA Tests
– Rapid Tests
– Strip Readers
o Allergen-Specific Immunodiagnostic Tests
o Immunoassay Analyzers
o Agglutination Tests
o Fluorinated Agglutination Tests
o Immunohistochemistry
o Western Blot Tests
o Non-Infection Immunoassays
o Complement Fixation
o Agar Gel Immunodiffusion
o Serum/Virus Neutralization
• Hematology
o Hematology Cartridges
o Hematology Analyzers
• Urinalysis
o Urinalysis Clips & Cartridges/Panels
o Urine Analyzers
o Urine Test Strips
• Molecular Diagnostics
o Polymer Chain Reaction Tests
o Microarrays
o DNA sequencing
o Genotyping
o DNA profiles
o Next-Generation Sequencing
o Others
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Companion Animal Diagnostics Market By Application
• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Pregnancy Testing
• Genetic Testing
• Toxicology Testing
• Revenue and growth forecasts from 2021 to 2031 for the Global Companion Animal Diagnostics Market By Animal Type
• Dogs
• Cats
• Horses
• Rabbits
• Birds
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Companion Animal Diagnostics Market By End User
• Veterinary Reference Laboratories
• Veterinary Hospitals and Clinics
• Point-of-care/In-house Testing
• Research Institutes and Universities
• Revenue and growth forecasts from 2021 to 2031 for the Global Companion Animal Diagnostics Market By Distribution Channel
• Direct Tender
• Retail Sales
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Companion Animal Diagnostics Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Companion Animal Diagnostics Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Companion Animal Diagnostics Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Companion Animal Diagnostics Market, with forecasts for Get our report today Companion Animal Diagnostics Market Forecast 2021-2031: By Technology, By Application, Animal Type, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Companion Animal Diagnostics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Companion Animal Diagnostics Market. Some of the company’s profiled in this report include
• IDEXX Laboratories, Inc.
• Zoetis Inc.
• Heska Corporation
• Thermo Fisher Scientific Inc.
• Virbac
• Neogen Corporation
• Biomérieux SA
• INDICAL Bioscience GmbH (QIAGEN N.V.)
• Fujifilm Holdings Corporation
• IDvet
• Randox Laboratories, Ltd.
• Mindray Medical International Limited (A Part of Excelsior Union Limited)
• Skyla
• Bionote Inc.
• Scil Animal Care Company GmbH
• Urit Medical Electronic Co., Ltd.
• Eurolyser Diagnostica GmbH
• Nova Biomedical
• Fassisi GmbH
• Swissavans AG
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Companion Animal Diagnostics Market Report 2021-2031: Forecasts by Technology (Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics, and Others), by Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Pregnancy testing, Genetic testing, and Toxicology testing), by Animal Type (Dogs, Cats, Horses, Rabbits, Birds, and Others), by End User (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities) by Distribution Channel (Direct Tender, and Retail Sales) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Companion Animal Diagnostics Market
2.1. Companion Animal Diagnostics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Application Submarkets Definitions
3. Companion Animal Diagnostics Market Overview
3.1. Global Companion Animal Diagnostics Market Size and Forecast By Region
3.2. Global Companion Animal Diagnostics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growth in the companion animal population
3.3.1.2. Increasing prevalence of Hypertensive
3.3.1.3. Increasing strategic initiatives in companion animal diagnostics market
3.3.1.4. Growing demand for companion animal diagnostics in Emerging economies
3.3.1.5. Surging investment in companion animal diagnostics
3.3.2. Market Restraints
3.3.2.1. Stringent regulation associated with product development
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Growing demand for rapid tests & portable instruments for point-of-care (POC) diagnostic services for companion animal
3.3.3.2. Use of advanced technologies to improve disease diagnosis accuracy in companion animals
3.3.4. Challenges
3.3.4.1. Increasing environmental concerns around the world
3.3.4.2. Low awareness regarding Companion Animals diseases
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Companion Animal Diagnostics Market Analysis and Forecast 2021-2031, By Technology (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Clinical Chemistry Analysis
4.1.1.1. Clinical Chemistry Analysis market size and forecast, 2021-2031 (USD Million)
4.1.2. Glucose Monitoring
4.1.2.1. Glucose Monitoring market size and forecast, 2021-2031 (USD Million)
4.1.3. Blood Gas & Electrolyte Analysis
4.1.3.1. Blood Gas & Electrolyte Analysis market size and forecast, 2021-2031 (USD Million)
4.1.4. Immunodiagnostics
4.1.4.1. Immunodiagnostics market size and forecast, 2021-2031 (USD Million)
4.1.5. Hematology
4.1.5.1. Hematology market size and forecast, 2021-2031 (USD Million)
4.1.6. Urinalysis
4.1.6.1. Urinalysis market size and forecast, 2021-2031 (USD Million)
4.1.7. Molecular Diagnostics
4.1.7.1. Molecular Diagnostics market size and forecast, 2021-2031 (USD Million)
4.1.8. Others
4.1.8.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Clinical Pathology
5.1.1.1. Clinical Pathology market size and forecast, 2021-2031 (USD Million)
5.1.2. Bacteriology
5.1.2.1. Bacteriology market size and forecast, 2021-2031 (USD Million)
5.1.3. Virology
5.1.3.1. Virology market size and forecast, 2021-2031 (USD Million)
5.1.4. Parasitology
5.1.4.1. Parasitology market size and forecast, 2021-2031 (USD Million)
5.1.5. Pregnancy Testing
5.1.5.1. Pregnancy Testing market size and forecast, 2021-2031 (USD Million)
5.1.6. Genetic Testing
5.1.6.1. Genetic Testing market size and forecast, 2021-2031 (USD Million)
5.1.7. Toxicology Testing
5.1.7.1. Toxicology Testing market size and forecast, 2021-2031 (USD Million)
6. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Animal Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Dogs
6.1.1.1. Dogs market size and forecast, 2021-2031 (USD Million)
6.1.2. Cats
6.1.2.1. Cats market size and forecast, 2021-2031 (USD Million)
6.1.3. Horses
6.1.3.1. Horses market size and forecast, 2021-2031 (USD Million)
6.1.4. Rabbits
6.1.4.1. Rabbits market size and forecast, 2021-2031 (USD Million)
6.1.5. Birds
6.1.5.1. Birds market size and forecast, 2021-2031 (USD Million)
6.1.6. Others
6.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
7. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Veterinary Reference Laboratories
7.1.1.1. Veterinary Reference Laboratories market size and forecast, 2021-2031 (USD Million)
7.1.2. Veterinary Hospitals and Clinics
7.1.2.1. Veterinary Hospitals and Clinics market size and forecast, 2021-2031 (USD Million)
7.1.3. Point-of-care/In-house Testing
7.1.3.1. Point-of-care/In-house Testing market size and forecast, 2021-2031 (USD Million)
7.1.4. Research Institutes and Universities
7.1.4.1. Research Institutes and Universities market size and forecast, 2021-2031 (USD Million)
8. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Companion Animal Diagnostics Market Size and Forecast By Technology
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Companion Animal Diagnostics Market Size and Forecast By Application
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Companion Animal Diagnostics Market Size and Forecast By Animal Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Companion Animal Diagnostics Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Companion Animal Diagnostics Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Companion Animal Diagnostics Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Companion Animal Diagnostics Market Size and Forecast By Technology
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Companion Animal Diagnostics Market Size and Forecast By Application
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Companion Animal Diagnostics Market Size and Forecast By Animal Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Companion Animal Diagnostics Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Companion Animal Diagnostics Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Companion Animal Diagnostics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Companion Animal Diagnostics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Companion Animal Diagnostics Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Technology
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Application
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Animal Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Companion Animal Diagnostics Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Companion Animal Diagnostics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Companion Animal Diagnostics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Companion Animal Diagnostics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Companion Animal Diagnostics Market Size and Forecast By Technology
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Companion Animal Diagnostics Market Size and Forecast By Application
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Companion Animal Diagnostics Market Size and Forecast By Animal Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Companion Animal Diagnostics Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
12.7. Brazil Companion Animal Diagnostics Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Companion Animal Diagnostics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Companion Animal Diagnostics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Companion Animal Diagnostics Market Size and Forecast By Technology
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Companion Animal Diagnostics Market Size and Forecast By Application
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Companion Animal Diagnostics Market Size and Forecast By Animal Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Companion Animal Diagnostics Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Companion Animal Diagnostics Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Companion Animal Diagnostics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Companion Animal Diagnostics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Companion Animal Diagnostics Market
14.1. IDEXX Laboratories, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Zoetis Inc.
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Heska Corporation
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Thermo Fisher Scientific Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Virbac
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Neogen Corporation
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Biomérieux SA
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. INDICAL Bioscience GmbH (QIAGEN N.V.)
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Fujifilm Holdings Corporation
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. IDvet
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Randox Laboratories, Ltd.
14.11.1. Company Snapshot
14.11.2. Company Overview
14.11.3. Financial Performance (2015-2019)
14.11.3.1. Net Revenue
14.11.3.2. Gross Profit
14.11.3.3. Geographical Revenue, 2019
14.11.4. Product Offerings
14.11.5. Recent Initiatives (2017-2019)
14.12. Mindray Medical International Limited (A Part of Excelsior Union Limited)
14.12.1. Company Snapshot
14.12.2. Company Overview
14.12.3. Financial Performance (2015-2019)
14.12.3.1. Net Revenue
14.12.3.2. Gross Profit
14.12.3.3. Geographical Revenue, 2019
14.12.4. Product Offerings
14.12.5. Recent Initiatives (2017-2019)
14.13. Skyla
14.13.1. Company Snapshot
14.13.2. Company Overview
14.13.3. Financial Performance (2015-2019)
14.13.3.1. Net Revenue
14.13.3.2. Gross Profit
14.13.3.3. Geographical Revenue, 2019
14.13.4. Product Offerings
14.13.5. Recent Initiatives (2017-2019)
14.14. Bionote Inc.
14.14.1. Company Snapshot
14.14.2. Company Overview
14.14.3. Financial Performance (2015-2019)
14.14.3.1. Net Revenue
14.14.3.2. Gross Profit
14.14.3.3. Geographical Revenue, 2019
14.14.4. Product Offerings
14.14.5. Recent Initiatives (2017-2019)
14.15. Scil Animal Care Company GmbH
14.15.1. Company Snapshot
14.15.2. Company Overview
14.15.3. Financial Performance (2015-2019)
14.15.3.1. Net Revenue
14.15.3.2. Gross Profit
14.15.3.3. Geographical Revenue, 2019
14.15.4. Product Offerings
14.15.5. Recent Initiatives (2017-2019)
14.16. Urit Medical Electronic Co., Ltd.
14.16.1. Company Snapshot
14.16.2. Company Overview
14.16.3. Financial Performance (2015-2019)
14.16.3.1. Net Revenue
14.16.3.2. Gross Profit
14.16.3.3. Geographical Revenue, 2019
14.16.4. Product Offerings
14.16.5. Recent Initiatives (2017-2019)
14.17. Eurolyser Diagnostica GmbH
14.17.1. Company Snapshot
14.17.2. Company Overview
14.17.3. Financial Performance (2015-2019)
14.17.3.1. Net Revenue
14.17.3.2. Gross Profit
14.17.3.3. Geographical Revenue, 2019
14.17.4. Product Offerings
14.17.5. Recent Initiatives (2017-2019)
14.18. Nova Biomedical
14.18.1. Company Snapshot
14.18.2. Company Overview
14.18.3. Financial Performance (2015-2019)
14.18.3.1. Net Revenue
14.18.3.2. Gross Profit
14.18.3.3. Geographical Revenue, 2019
14.18.4. Product Offerings
14.18.5. Recent Initiatives (2017-2019)
14.19. Fassisi GmbH
14.19.1. Company Snapshot
14.19.2. Company Overview
14.19.3. Financial Performance (2015-2019)
14.19.3.1. Net Revenue
14.19.3.2. Gross Profit
14.19.3.3. Geographical Revenue, 2019
14.19.4. Product Offerings
14.19.5. Recent Initiatives (2017-2019)
14.20. Swissavans AG
14.20.1. Company Snapshot
14.20.2. Company Overview
14.20.3. Financial Performance (2015-2019)
14.20.3.1. Net Revenue
14.20.3.2. Gross Profit
14.20.3.3. Geographical Revenue, 2019
14.20.4. Product Offerings
14.20.5. Recent Initiatives (2017-2019)
14.21. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Companion Animal Diagnostics Market Drivers & Restraints 2021
Table 7. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Rabbits h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 158. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 163. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 208. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Leading 20 Companion Animal Diagnostics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 382. IDEXX Laboratories, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 383. IDEXX Laboratories, Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 384. Zoetis Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Zoetis Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 386. Heska Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 387. Heska Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 388. Thermo Fisher Scientific Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 389. Thermo Fisher Scientific Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 390. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 391. Virbac Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 392. Neogen Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 393. Neogen Corporation Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 394. Biomérieux SA Profile 2019 (CEO, HQ, Founded, Website)
Table 395. Biomérieux SA Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 396. INDICAL Bioscience GmbH (QIAGEN N.V.) Profile 2019 (CEO, HQ, Founded, Website)
Table 397. INDICAL Bioscience GmbH (QIAGEN N.V.) Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 398. Fujifilm Holdings Profile 2019 (CEO, HQ, Founded, Website)
Table 399. Fujifilm Holdings Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 400. IDvet Profile 2019 (CEO, HQ, Founded, Website)
Table 401. IDvet Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 402. Scil Animal Care Company GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Scil Animal Care Company GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 404. Randox Laboratories, Ltd.Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Randox Laboratories, Ltd.Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 406. Mindray Medical International Limited (A Part of Excelsior Union Limited) Profile 2019 (CEO, HQ, Founded, Website)
Table 407. Mindray Medical International Limited (A Part of Excelsior Union Limited) Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 408. Skyla Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Skyla . Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 410. Bionote Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 411. Bionote Inc.. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 412. Scil Animal Care Company GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Scil Animal Care Company GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 414. Urit Medical Electronic Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 415. Urit Medical Electronic Co., Ltd. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 416. Eurolyser Diagnostica GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 417. Eurolyser Diagnostica GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 418. Nova Biomedical Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Nova Biomedical Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 420. Fassisi GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Fassisi GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 422. Swissavans AG Profile 2019 (CEO, HQ, Founded, Website)
Table 423. Swissavans AG Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 424. Other Companies Involved in the Companion Animal Diagnostics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Companion Animal Diagnostics Market Drivers & Restraints 2021
Figure 7. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 33. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Rabbits h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 158. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 163. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 208. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Porter’s Five Force Analysis
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Companion Animal Diagnostics Market
2.1. Companion Animal Diagnostics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Application Submarkets Definitions
3. Companion Animal Diagnostics Market Overview
3.1. Global Companion Animal Diagnostics Market Size and Forecast By Region
3.2. Global Companion Animal Diagnostics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growth in the companion animal population
3.3.1.2. Increasing prevalence of Hypertensive
3.3.1.3. Increasing strategic initiatives in companion animal diagnostics market
3.3.1.4. Growing demand for companion animal diagnostics in Emerging economies
3.3.1.5. Surging investment in companion animal diagnostics
3.3.2. Market Restraints
3.3.2.1. Stringent regulation associated with product development
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Growing demand for rapid tests & portable instruments for point-of-care (POC) diagnostic services for companion animal
3.3.3.2. Use of advanced technologies to improve disease diagnosis accuracy in companion animals
3.3.4. Challenges
3.3.4.1. Increasing environmental concerns around the world
3.3.4.2. Low awareness regarding Companion Animals diseases
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Companion Animal Diagnostics Market Analysis and Forecast 2021-2031, By Technology (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Clinical Chemistry Analysis
4.1.1.1. Clinical Chemistry Analysis market size and forecast, 2021-2031 (USD Million)
4.1.2. Glucose Monitoring
4.1.2.1. Glucose Monitoring market size and forecast, 2021-2031 (USD Million)
4.1.3. Blood Gas & Electrolyte Analysis
4.1.3.1. Blood Gas & Electrolyte Analysis market size and forecast, 2021-2031 (USD Million)
4.1.4. Immunodiagnostics
4.1.4.1. Immunodiagnostics market size and forecast, 2021-2031 (USD Million)
4.1.5. Hematology
4.1.5.1. Hematology market size and forecast, 2021-2031 (USD Million)
4.1.6. Urinalysis
4.1.6.1. Urinalysis market size and forecast, 2021-2031 (USD Million)
4.1.7. Molecular Diagnostics
4.1.7.1. Molecular Diagnostics market size and forecast, 2021-2031 (USD Million)
4.1.8. Others
4.1.8.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Clinical Pathology
5.1.1.1. Clinical Pathology market size and forecast, 2021-2031 (USD Million)
5.1.2. Bacteriology
5.1.2.1. Bacteriology market size and forecast, 2021-2031 (USD Million)
5.1.3. Virology
5.1.3.1. Virology market size and forecast, 2021-2031 (USD Million)
5.1.4. Parasitology
5.1.4.1. Parasitology market size and forecast, 2021-2031 (USD Million)
5.1.5. Pregnancy Testing
5.1.5.1. Pregnancy Testing market size and forecast, 2021-2031 (USD Million)
5.1.6. Genetic Testing
5.1.6.1. Genetic Testing market size and forecast, 2021-2031 (USD Million)
5.1.7. Toxicology Testing
5.1.7.1. Toxicology Testing market size and forecast, 2021-2031 (USD Million)
6. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Animal Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Dogs
6.1.1.1. Dogs market size and forecast, 2021-2031 (USD Million)
6.1.2. Cats
6.1.2.1. Cats market size and forecast, 2021-2031 (USD Million)
6.1.3. Horses
6.1.3.1. Horses market size and forecast, 2021-2031 (USD Million)
6.1.4. Rabbits
6.1.4.1. Rabbits market size and forecast, 2021-2031 (USD Million)
6.1.5. Birds
6.1.5.1. Birds market size and forecast, 2021-2031 (USD Million)
6.1.6. Others
6.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
7. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Veterinary Reference Laboratories
7.1.1.1. Veterinary Reference Laboratories market size and forecast, 2021-2031 (USD Million)
7.1.2. Veterinary Hospitals and Clinics
7.1.2.1. Veterinary Hospitals and Clinics market size and forecast, 2021-2031 (USD Million)
7.1.3. Point-of-care/In-house Testing
7.1.3.1. Point-of-care/In-house Testing market size and forecast, 2021-2031 (USD Million)
7.1.4. Research Institutes and Universities
7.1.4.1. Research Institutes and Universities market size and forecast, 2021-2031 (USD Million)
8. Global Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Companion Animal Diagnostics Market Size and Forecast By Technology
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Companion Animal Diagnostics Market Size and Forecast By Application
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Companion Animal Diagnostics Market Size and Forecast By Animal Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Companion Animal Diagnostics Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Companion Animal Diagnostics Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Companion Animal Diagnostics Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Companion Animal Diagnostics Market Size and Forecast By Technology
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Companion Animal Diagnostics Market Size and Forecast By Application
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Companion Animal Diagnostics Market Size and Forecast By Animal Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Companion Animal Diagnostics Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Companion Animal Diagnostics Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Companion Animal Diagnostics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Companion Animal Diagnostics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Companion Animal Diagnostics Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Technology
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Application
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Animal Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Companion Animal Diagnostics Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Companion Animal Diagnostics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Companion Animal Diagnostics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Companion Animal Diagnostics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Companion Animal Diagnostics Market Size and Forecast By Technology
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Companion Animal Diagnostics Market Size and Forecast By Application
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Companion Animal Diagnostics Market Size and Forecast By Animal Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Companion Animal Diagnostics Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
12.7. Brazil Companion Animal Diagnostics Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Companion Animal Diagnostics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Companion Animal Diagnostics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Companion Animal Diagnostics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Companion Animal Diagnostics Market Size and Forecast By Technology
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Companion Animal Diagnostics Market Size and Forecast By Application
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Companion Animal Diagnostics Market Size and Forecast By Animal Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Companion Animal Diagnostics Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Companion Animal Diagnostics Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Companion Animal Diagnostics Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Companion Animal Diagnostics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Companion Animal Diagnostics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Companion Animal Diagnostics Market
14.1. IDEXX Laboratories, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Zoetis Inc.
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Heska Corporation
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Thermo Fisher Scientific Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Virbac
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Neogen Corporation
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Biomérieux SA
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. INDICAL Bioscience GmbH (QIAGEN N.V.)
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Fujifilm Holdings Corporation
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. IDvet
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Randox Laboratories, Ltd.
14.11.1. Company Snapshot
14.11.2. Company Overview
14.11.3. Financial Performance (2015-2019)
14.11.3.1. Net Revenue
14.11.3.2. Gross Profit
14.11.3.3. Geographical Revenue, 2019
14.11.4. Product Offerings
14.11.5. Recent Initiatives (2017-2019)
14.12. Mindray Medical International Limited (A Part of Excelsior Union Limited)
14.12.1. Company Snapshot
14.12.2. Company Overview
14.12.3. Financial Performance (2015-2019)
14.12.3.1. Net Revenue
14.12.3.2. Gross Profit
14.12.3.3. Geographical Revenue, 2019
14.12.4. Product Offerings
14.12.5. Recent Initiatives (2017-2019)
14.13. Skyla
14.13.1. Company Snapshot
14.13.2. Company Overview
14.13.3. Financial Performance (2015-2019)
14.13.3.1. Net Revenue
14.13.3.2. Gross Profit
14.13.3.3. Geographical Revenue, 2019
14.13.4. Product Offerings
14.13.5. Recent Initiatives (2017-2019)
14.14. Bionote Inc.
14.14.1. Company Snapshot
14.14.2. Company Overview
14.14.3. Financial Performance (2015-2019)
14.14.3.1. Net Revenue
14.14.3.2. Gross Profit
14.14.3.3. Geographical Revenue, 2019
14.14.4. Product Offerings
14.14.5. Recent Initiatives (2017-2019)
14.15. Scil Animal Care Company GmbH
14.15.1. Company Snapshot
14.15.2. Company Overview
14.15.3. Financial Performance (2015-2019)
14.15.3.1. Net Revenue
14.15.3.2. Gross Profit
14.15.3.3. Geographical Revenue, 2019
14.15.4. Product Offerings
14.15.5. Recent Initiatives (2017-2019)
14.16. Urit Medical Electronic Co., Ltd.
14.16.1. Company Snapshot
14.16.2. Company Overview
14.16.3. Financial Performance (2015-2019)
14.16.3.1. Net Revenue
14.16.3.2. Gross Profit
14.16.3.3. Geographical Revenue, 2019
14.16.4. Product Offerings
14.16.5. Recent Initiatives (2017-2019)
14.17. Eurolyser Diagnostica GmbH
14.17.1. Company Snapshot
14.17.2. Company Overview
14.17.3. Financial Performance (2015-2019)
14.17.3.1. Net Revenue
14.17.3.2. Gross Profit
14.17.3.3. Geographical Revenue, 2019
14.17.4. Product Offerings
14.17.5. Recent Initiatives (2017-2019)
14.18. Nova Biomedical
14.18.1. Company Snapshot
14.18.2. Company Overview
14.18.3. Financial Performance (2015-2019)
14.18.3.1. Net Revenue
14.18.3.2. Gross Profit
14.18.3.3. Geographical Revenue, 2019
14.18.4. Product Offerings
14.18.5. Recent Initiatives (2017-2019)
14.19. Fassisi GmbH
14.19.1. Company Snapshot
14.19.2. Company Overview
14.19.3. Financial Performance (2015-2019)
14.19.3.1. Net Revenue
14.19.3.2. Gross Profit
14.19.3.3. Geographical Revenue, 2019
14.19.4. Product Offerings
14.19.5. Recent Initiatives (2017-2019)
14.20. Swissavans AG
14.20.1. Company Snapshot
14.20.2. Company Overview
14.20.3. Financial Performance (2015-2019)
14.20.3.1. Net Revenue
14.20.3.2. Gross Profit
14.20.3.3. Geographical Revenue, 2019
14.20.4. Product Offerings
14.20.5. Recent Initiatives (2017-2019)
14.21. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Companion Animal Diagnostics Market Drivers & Restraints 2021
Table 7. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Rabbits h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 158. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 163. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 208. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Leading 20 Companion Animal Diagnostics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 382. IDEXX Laboratories, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 383. IDEXX Laboratories, Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 384. Zoetis Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Zoetis Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 386. Heska Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 387. Heska Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 388. Thermo Fisher Scientific Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 389. Thermo Fisher Scientific Inc. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 390. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 391. Virbac Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 392. Neogen Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 393. Neogen Corporation Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 394. Biomérieux SA Profile 2019 (CEO, HQ, Founded, Website)
Table 395. Biomérieux SA Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 396. INDICAL Bioscience GmbH (QIAGEN N.V.) Profile 2019 (CEO, HQ, Founded, Website)
Table 397. INDICAL Bioscience GmbH (QIAGEN N.V.) Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 398. Fujifilm Holdings Profile 2019 (CEO, HQ, Founded, Website)
Table 399. Fujifilm Holdings Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 400. IDvet Profile 2019 (CEO, HQ, Founded, Website)
Table 401. IDvet Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 402. Scil Animal Care Company GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Scil Animal Care Company GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 404. Randox Laboratories, Ltd.Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Randox Laboratories, Ltd.Companion Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 406. Mindray Medical International Limited (A Part of Excelsior Union Limited) Profile 2019 (CEO, HQ, Founded, Website)
Table 407. Mindray Medical International Limited (A Part of Excelsior Union Limited) Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 408. Skyla Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Skyla . Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 410. Bionote Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 411. Bionote Inc.. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 412. Scil Animal Care Company GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Scil Animal Care Company GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 414. Urit Medical Electronic Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 415. Urit Medical Electronic Co., Ltd. Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 416. Eurolyser Diagnostica GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 417. Eurolyser Diagnostica GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 418. Nova Biomedical Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Nova Biomedical Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 420. Fassisi GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Fassisi GmbH Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 422. Swissavans AG Profile 2019 (CEO, HQ, Founded, Website)
Table 423. Swissavans AG Animal Diagnostics Product Offering (Segment, Product Offerings)
Table 424. Other Companies Involved in the Companion Animal Diagnostics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Companion Animal Diagnostics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Companion Animal Diagnostics Market Drivers & Restraints 2021
Figure 7. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Clinical Chemistry Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Glucose Monitoring Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Blood Gas & Electrolyte Analysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Immunodiagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 33. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Hematology Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Urinalysis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Molecular Diagnostics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Clinical Pathology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Bacteriology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Virology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Parasitology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Pregnancy Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Genetic Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Toxicology Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Companion Animal Diagnostics Market Forecast By Animal Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Dogs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Cats Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Horses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Rabbits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Rabbits h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Birds Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Veterinary Reference Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Veterinary Hospitals and Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Point-of-care/In-house Testing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 158. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 163. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. North America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. North America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. North America Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. US Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Canada Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 208. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Europe Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. Europe Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Europe Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Europe Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. UK Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Germany Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. France Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Rest of Europe Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Asia Pacific Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Companion Animal Diagnostics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. China Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. India Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Japan Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. RoAPAC Companion Animal Diagnostics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Middle East Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Companion Animal Diagnostics Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Companion Animal Diagnostics Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Companion Animal Diagnostics Market Forecast By Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Companion Animal Diagnostics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Companion Animal Diagnostics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Porter’s Five Force Analysis
Companies Profiled in the Report
1. IDEXX Laboratories, Inc.
2. Zoetis Inc.
3. Heska Corporation
4. Thermo Fisher Scientific Inc.
5. Virbac
6. Neogen Corporation
7. Biomérieux SA
8. INDICAL Bioscience GmbH (QIAGEN N.V.)
9. Fujifilm Holdings Corporation
10. IDvet
11. Randox Laboratories, Ltd.
12. Mindray Medical International Limited (A Part of Excelsior Union Limited)
13. Skyla
14. Bionote Inc.
15. Scil Animal Care Company GmbH
16. Urit Medical Electronic Co., Ltd.
17. Eurolyser Diagnostica GmbH
18. Nova Biomedical
19. Fassisi GmbH
20. Swissavans AG
List of Companies Mentioned in the Report:
1. Abbott
2. DiaSorin S.p.A.
3. F. Hoffmann-La Roche Ltd
4. bioMérieux SA
5. QIAGEN
6. Hologic, Inc.
7. Merck KGaA
8. Thermo Fisher Scientific Inc.
9. Beckman Coulter, Inc. ( a subsidiary of Danaher)
10. Siemens Healthcare GmbH
11. Bio-Rad Laboratories, Inc.
12. AdvaCare Pharma
13. AbbVie Inc.
14. Johnson & Johnson Services, Inc.
15. Gilead Sciences, Inc.
16. ViiV Healthcare group of companies.
17. Gilead Sciences, Inc.
18. Janssen Global Services, LLC
19. Merck & Co., Inc.
20. Mylan N.V.
21. PointCare
22. Atomo Diagnostics
23. Chembio Diagnostic Systems, Inc.
24. OraSure Technologies, Inc.
25. BD
26. ACON Laboratories Inc.
27. Hemosure, Inc.
28. MicroGen Diagnostics
29. Grifols, S.A
30. BODITECH MED INC.
31. Chembio Diagnostic Systems, Inc.
32. Nanoentek
33. BIOMEDOMICS INC
34. EKF Diagnostics Holdings plc
35. PerkinElmer Inc.
36. ARKRAY USA, Inc.
37. Biohit Oyj
38. Germaine Laboratories, Inc.
39. Quidel Corporation
40. HUMASIS.
41. Illumina, Inc.
42. Lamdagen Corporation
43. LifeSign LLC.
44. Medixbiochemica
45. Nova Biomedical
46. Sannuo Biosensing Co., Ltd.
47. STRECK
48. Sysmex Corporation
49. Avecon Healthcare Pvt Ltd
50. Maccura Biotechnology Co., Ltd.
51. bioLytical Laboratories Inc.
52. Diagnosis S.A.
53. Chembio Diagnostic Systems, Inc.
54. Nanoentek
55. Diagenode Diagnostics
List of Organizations Mentioned in the Report:
1. American Veterinary Medical Association
2. World Veterinary Association
3. Student American Veterinary Medical Association
4. American Association of Bovine Practitioners
5. British Veterinary Association
6. European Medicines Agency (EMA)
7. Food and Drug Administration (FDA)
8. Agência Nacional de Vigilância Sanitária (ANVISA)
9. National Institutes of Health (NIH)
10. World Health Organization (WHO)
1. IDEXX Laboratories, Inc.
2. Zoetis Inc.
3. Heska Corporation
4. Thermo Fisher Scientific Inc.
5. Virbac
6. Neogen Corporation
7. Biomérieux SA
8. INDICAL Bioscience GmbH (QIAGEN N.V.)
9. Fujifilm Holdings Corporation
10. IDvet
11. Randox Laboratories, Ltd.
12. Mindray Medical International Limited (A Part of Excelsior Union Limited)
13. Skyla
14. Bionote Inc.
15. Scil Animal Care Company GmbH
16. Urit Medical Electronic Co., Ltd.
17. Eurolyser Diagnostica GmbH
18. Nova Biomedical
19. Fassisi GmbH
20. Swissavans AG
List of Companies Mentioned in the Report:
1. Abbott
2. DiaSorin S.p.A.
3. F. Hoffmann-La Roche Ltd
4. bioMérieux SA
5. QIAGEN
6. Hologic, Inc.
7. Merck KGaA
8. Thermo Fisher Scientific Inc.
9. Beckman Coulter, Inc. ( a subsidiary of Danaher)
10. Siemens Healthcare GmbH
11. Bio-Rad Laboratories, Inc.
12. AdvaCare Pharma
13. AbbVie Inc.
14. Johnson & Johnson Services, Inc.
15. Gilead Sciences, Inc.
16. ViiV Healthcare group of companies.
17. Gilead Sciences, Inc.
18. Janssen Global Services, LLC
19. Merck & Co., Inc.
20. Mylan N.V.
21. PointCare
22. Atomo Diagnostics
23. Chembio Diagnostic Systems, Inc.
24. OraSure Technologies, Inc.
25. BD
26. ACON Laboratories Inc.
27. Hemosure, Inc.
28. MicroGen Diagnostics
29. Grifols, S.A
30. BODITECH MED INC.
31. Chembio Diagnostic Systems, Inc.
32. Nanoentek
33. BIOMEDOMICS INC
34. EKF Diagnostics Holdings plc
35. PerkinElmer Inc.
36. ARKRAY USA, Inc.
37. Biohit Oyj
38. Germaine Laboratories, Inc.
39. Quidel Corporation
40. HUMASIS.
41. Illumina, Inc.
42. Lamdagen Corporation
43. LifeSign LLC.
44. Medixbiochemica
45. Nova Biomedical
46. Sannuo Biosensing Co., Ltd.
47. STRECK
48. Sysmex Corporation
49. Avecon Healthcare Pvt Ltd
50. Maccura Biotechnology Co., Ltd.
51. bioLytical Laboratories Inc.
52. Diagnosis S.A.
53. Chembio Diagnostic Systems, Inc.
54. Nanoentek
55. Diagenode Diagnostics
List of Organizations Mentioned in the Report:
1. American Veterinary Medical Association
2. World Veterinary Association
3. Student American Veterinary Medical Association
4. American Association of Bovine Practitioners
5. British Veterinary Association
6. European Medicines Agency (EMA)
7. Food and Drug Administration (FDA)
8. Agência Nacional de Vigilância Sanitária (ANVISA)
9. National Institutes of Health (NIH)
10. World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Companion Animal Diagnostics Market Report 2021-2031Related reports
Animal Health Market Report 2021-2031
The animal health sector is anticipated to evolve at a rapid pace. The veterinary health industry has diverse opportunities to...Full DetailsPublished: 28 January 2021Animal Nutrition Ingredients Market Report to 2031
Where is the Animal Nutrition Ingredients market heading? If you are involved in this sector you must read this newly...Full DetailsPublished: 01 January 1970Pet Care E-Commerce Market Report 2020-2030
The increase in the number of pets globally and increasing the purchasing power of the pet owners are increasing the...
Full DetailsPublished: 01 January 1970Veterinary Chemistry Analyzer Market Forecast 2020-2030
As clinic blood samples are used, health and safety rules require universal precautions to be observed during the treatment of...Full DetailsPublished: 01 January 1970Point of Care Diagnostics Market Report 2020-2030
The government support to promote the adoption of these diagnostic tests, technological advancement, increased inclination for home healthcare, and rise...
Full DetailsPublished: 01 January 1970Poultry Diagnostics Market Report 2020-2030
Many companies are trying to increase the awareness regarding the importance of poultry diagnostics.
...Full DetailsPublished: 01 January 1970Acid & Nutrient in Animal Nutrition Market Report 2021-2031
Growing animal feed use is a major factor driving the overall market growth of the acid and nutrition market. Further,...
Full DetailsPublished: 01 January 1970Animal Parasiticides Market Report to 2031
Where is the Global Animal Parasiticides market heading? If you are involved in this sector you must read this newly...Full DetailsPublished: 01 January 1970North American Molecular Diagnostics (MDx) Market Report 2021-2031
In order to improve health outcomes, molecular diagnostic testing for genetic or pathogenic diseases is necessary to provide easy, fast...Full DetailsPublished: 17 February 2021Animal Vaccine Market Report to 2031
Where is the Animal Vaccines market heading? If you are involved in this sector you must read this newly updated...Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Companion Animal Diagnostics Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033
The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.
29 March 2023
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
